These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25248333)

  • 21. Neutral polymer micelle carriers with pH-responsive, endosome-releasing activity modulate antigen trafficking to enhance CD8(+) T cell responses.
    Keller S; Wilson JT; Patilea GI; Kern HB; Convertine AJ; Stayton PS
    J Control Release; 2014 Oct; 191():24-33. PubMed ID: 24698946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-functional nanocomplex codelivery of Trp2 and R837 to activate melanoma-specific immunity.
    Ji Z; Tan Z; Li M; Tao J; Guan E; Du J; Hu Y
    Int J Pharm; 2020 May; 582():119310. PubMed ID: 32276088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Porcine neonatal blood dendritic cells, but not monocytes, are more responsive to TLRs stimulation than their adult counterparts.
    Auray G; Facci MR; van Kessel J; Buchanan R; Babiuk LA; Gerdts V
    PLoS One; 2013; 8(5):e59629. PubMed ID: 23667422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Directing vaccine immune responses to mucosa by nanosized particulate carriers encapsulating NOD ligands.
    Pavot V; Climent N; Rochereau N; Garcia F; Genin C; Tiraby G; Vernejoul F; Perouzel E; Lioux T; Verrier B; Paul S
    Biomaterials; 2016 Jan; 75():327-339. PubMed ID: 26539801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glyco-Nanoadjuvants: Sugar Structures on Carriers of a Small Molecule TLR7 Ligand Affect Their Immunostimulatory Activities.
    Shinchi H; Yuki M; Yamauchi T; Niimura M; Wakao M; Cottam HB; Hayashi T; Carson DA; Moroishi T; Suda Y
    ACS Appl Bio Mater; 2021 Mar; 4(3):2732-2741. PubMed ID: 35014312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The TLR7 agonists imiquimod and gardiquimod improve DC-based immunotherapy for melanoma in mice.
    Ma F; Zhang J; Zhang J; Zhang C
    Cell Mol Immunol; 2010 Sep; 7(5):381-8. PubMed ID: 20543857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-Delivery of Imiquimod and Plasmid DNA via an Amphiphilic pH-Responsive Star Polymer that Forms Unimolecular Micelles in Water.
    Lin W; Yao N; Li H; Hanson S; Han W; Wang C; Zhang L
    Polymers (Basel); 2016 Nov; 8(11):. PubMed ID: 30974677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential of NOD receptor ligands as immunomodulators in particulate vaccine carriers.
    Wischke C; Mathew S; Roch T; Frentsch M; Lendlein A
    J Control Release; 2012 Dec; 164(3):299-306. PubMed ID: 22771980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of alum in improving the immunogenicity of biodegradable polymer particle entrapped antigens.
    Kanchan V; Katare YK; Panda AK
    Eur J Pharm Sci; 2009 Aug; 38(1):18-28. PubMed ID: 19467323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HPMA-Based Nanocarriers for Effective Immune System Stimulation.
    Kramer S; Langhanki J; Krumb M; Opatz T; Bros M; Zentel R
    Macromol Biosci; 2019 Jun; 19(6):e1800481. PubMed ID: 30968573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation, characterization, in vivo pharmacokinetics, and biodistribution of polymeric micellar dimethoxycurcumin for tumor targeting.
    Liu H; Xu H; Jiang Y; Hao S; Gong F; Mu H; Liu K
    Int J Nanomedicine; 2015; 10():6395-410. PubMed ID: 26504386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymeric micelles with citraconic amide as pH-sensitive bond in backbone for anticancer drug delivery.
    Cao J; Su T; Zhang L; Liu R; Wang G; He B; Gu Z
    Int J Pharm; 2014 Aug; 471(1-2):28-36. PubMed ID: 24836667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating dendritic cells as an in vitro screening tool for immunotherapeutic formulations.
    El-Murr T; Patel A; Sedlak C; D'Souza-Lobo B
    J Immunol Methods; 2018 Aug; 459():55-62. PubMed ID: 29800576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The toll-like receptor ligands Hiltonol
    Patchett AL; Tovar C; Corcoran LM; Lyons AB; Woods GM
    Dev Comp Immunol; 2017 Nov; 76():352-360. PubMed ID: 28689773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folate-conjugated amphiphilic star-shaped block copolymers as targeted nanocarriers.
    Zhu J; Zhou Z; Yang C; Kong D; Wan Y; Wang Z
    J Biomed Mater Res A; 2011 Jun; 97(4):498-508. PubMed ID: 21509931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of Toll-like receptor 7/8 agonists as vaccine adjuvants.
    Vasilakos JP; Tomai MA
    Expert Rev Vaccines; 2013 Jul; 12(7):809-19. PubMed ID: 23885825
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Pan Q; Zhang Q; Chu J; Pais R; Liu S; He C; Eko FO
    Front Cell Infect Microbiol; 2017; 7():514. PubMed ID: 29326885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunopotentiator-Loaded Polymeric Microparticles as Robust Adjuvant to Improve Vaccine Efficacy.
    Zhang W; Wang L; Yang T; Liu Y; Chen X; Liu Q; Jia J; Ma G
    Pharm Res; 2015 Sep; 32(9):2837-50. PubMed ID: 26017300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer.
    Xu W; Siddiqui IA; Nihal M; Pilla S; Rosenthal K; Mukhtar H; Gong S
    Biomaterials; 2013 Jul; 34(21):5244-53. PubMed ID: 23582862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of the Immunostimulatory Activity of a TLR7 Ligand by Conjugation to Polysaccharides.
    Shinchi H; Crain B; Yao S; Chan M; Zhang SS; Ahmadiiveli A; Suda Y; Hayashi T; Cottam HB; Carson DA
    Bioconjug Chem; 2015 Aug; 26(8):1713-23. PubMed ID: 26193334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.